Medicine & Life Sciences
Migraine Disorders
100%
ubrogepant
39%
Headache
28%
Brain
26%
Cognition
26%
Neurons
25%
Memory
25%
Cognitive Dysfunction
25%
Sleep
23%
Dementia
23%
Systematic Reviews
22%
Epilepsy
21%
Therapeutics
21%
Anxiety
21%
Health
19%
Intracranial Aneurysm
19%
Depression
18%
Psychiatry
18%
Hispanic Americans
17%
Pediatrics
16%
(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate
15%
Child
15%
Spine
15%
Aneurysm
15%
Stroke
15%
Odds Ratio
14%
Confidence Intervals
14%
Safety
14%
Placebos
14%
Seizures
14%
Population
14%
Biomarkers
13%
Neuronal Plasticity
13%
Traumatic Brain Injury
13%
Auditory Cortex
13%
Women's Health
12%
Epidemiology
12%
Sleep Initiation and Maintenance Disorders
12%
Randomized Controlled Trials
11%
Biological Psychiatry
11%
Equipment and Supplies
11%
Pain
11%
Data Analysis
11%
Mortality
11%
Sodium Oxybate
11%
Neuroglia
11%
Cataplexy
10%
Cohort Studies
10%
Alzheimer Disease
10%
Type A Botulinum Toxins
10%
Guidelines
10%
Mental Health
10%
Neoplasms
10%
AMPA Receptors
9%
Pandemics
9%
Narcolepsy
9%
Gap Junctions
9%
Dentate Gyrus
9%
Health Care Outcome Assessment
9%
Demography
9%
Percussion
9%
Primary Health Care
9%
Advisory Committees
8%
Nutrition Assessment
8%
Proteins
8%
Delivery of Health Care
8%
Calcitonin Gene-Related Peptide
8%
Phenotype
8%
Reward
8%
Clinical Trials
8%
Frailty
8%
human PANX1 protein
8%
Autism Spectrum Disorder
8%
Gait
8%
Comorbidity
8%
Neoplasm Metastasis
8%
Efficiency
8%
Actigraphy
8%
Meningioma
8%
Wounds and Injuries
7%
eptinezumab
7%
Natural History
7%
Connexins
7%
Prescription Drug Overuse
7%
Chromatin
7%
Inflammation
7%
Sleepiness
7%
Multicenter Studies
7%
Longitudinal Studies
7%
triheptanoin
7%
Language
7%
Logistic Models
7%
Mental Status and Dementia Tests
7%
Social Determinants of Health
7%
Blood Pressure
7%
Quality of Life
7%
erenumab
7%
Hospitalization
7%
TARP
7%
Medicaid
6%